Tools
Stock profile

Solventum Corp (SOLV)

SOLV · Latest close $86.48 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$86.48
As of Nov 18, 2026
Tracked funds holding
8 of 149
2026 Q2 13F filings
Opened / added
0 / 2
vs previous quarter
Trimmed / exited
5
vs previous quarter

Solventum Corp (SOLV) is held by 8 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds adding and 5 funds trimming or exiting versus the previous quarter. Latest close $86.48 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Trian Fund Management · Independent Franchise Partners · Davis Advisors — 8 tracked funds hold SOLV. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

Vale S.A. (VALE) · KONINKLIJKE PHILIPS NV (PHG) · AMERICAN TOWER CORP /MA/ (AMT) · SYSCO CORP (SYY) · Bank of New York Mellon Corp (BNY) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Trian Fund Management15.02%8,236,753HELD Q3 filed Nov 16
Independent Franchise Partners8.18%16,170,038ADDED (+2.8%) Q3 filed Nov 13
Davis Advisors2.09%6,307,729TRIMMED (-0.4%) Q3 filed Nov 10
Investment Management Associates1.67%105,417TRIMMED (-10.1%) Q3 filed Oct 29
Pzena Investment Management0.09%417,770TRIMMED (-5.0%) Q3 filed Oct 30
Mairs & Power Funds0.05%72,441TRIMMED (-0.1%) Q3 filed Nov 16
Edgewood Management0.05%64,611TRIMMED (-0.2%) Q3 filed Nov 12
Mondrian Investment Partners0.02%15,486ADDED (+5.4%) Q3 filed Oct 23

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +9.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

92.4461.292024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding876 of 8,857 filers
Long-only filers among them873
Change vs 2026 Q1+16 net · 800 entered · 784 exited
Shares reported, all filers127,323,217
Reported value, all filers$9.7B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$8.3B
Net income · FY2025$1.6B
Total assets · FY2025$14.3B
Shares outstanding170,223,729
Market cap (at latest close)$14.7B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 20264,952,208
Share of shares outstanding2.91%
Days to cover4.71

Shares short at recent settlements — Jul 31, 2026: 3.5M · Aug 14, 2026: 3.5M · Aug 31, 2026: 4.3M · Sep 15, 2026: 4.9M · Sep 30, 2026: 4.9M · Oct 15, 2026: 5.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 4K · Sep 15, 2026: 0 · Sep 30, 2026: 119 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 30, 2026Vanguard Capital ManagementSC 13G10,875,3106.3%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Jan 27, 2026Independent Franchise Partners, LLPSC 13G/A15,355,6918.8%Dec 31, 2025SEC filing
Nov 13, 2025Independent Franchise Partners, LLPSC 13G/A12,899,2407.4%Sep 30, 2025SEC filing
Aug 18, 20253M CompanySC 13G/A25,569,19014.8%Aug 15, 2025SEC filing
Aug 13, 2025Independent Franchise Partners, LLPSC 13G10,141,0665.9%Jun 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 59 Lobbying Disclosure Act filings named this company as client, 2017–2026; most common issues: Health Issues (59), Medicare/Medicaid (53), Trade (domestic/foreign) (16).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Greenblatt Magic Formula — High earnings yield and high return on capital together

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Greenblatt Magic Formula — Earnings yield: 9.5% · Return on capital: 106.4% · Combined rank: 7

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.38 · Operating cash flow: $369.0M · Net income: $1.6B

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together366.7%+3.3%+7.3%-4.0%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold SOLV — ranked by lift, the co-holding pattern described in Methodology: Vale S.A. (VALE) · KONINKLIJKE PHILIPS NV (PHG) · AMERICAN TOWER CORP /MA/ (AMT) · SYSCO CORP (SYY) · Bank of New York Mellon Corp (BNY) · BAXTER INTERNATIONAL INC (BAX) · FISERV INC (FISV) · ADOBE INC. (ADBE).

Recent 8-K filings

FiledItemsSource
Nov 5, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 5, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 5, 20267.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Vale S.A. (VALE) · Track Record: how the signals scored · Practice timing on SOLV

One email a week: the week’s new filings and research. Subscribe free

← SOLS  ·  SON →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.